Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Aftimos

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Seminars in Cancer Biology|December 27, 2017
Network science in clinical trials: A patient-centered approachVenkata S K Manem, Roberto Salgado, Philippe Aftimos, et al.
Breast (Edinburgh, Scotland)|May 6, 2014
Cardiotoxicity of systemic agents used in breast cancerFelipe Ades, Dimitrios Zardavas, Ana Catarina Pinto, et al.
The Oncologist|July 21, 2021
Analyses of the Rationale and Implementation of Research Biopsies in Oncology Clinical Trials at a Tertiary Cancer CenterNathalie Olympios, Laetitia Collet, Marianne Paesmans, et al.
Journal of Medical Case Reports|October 30, 2017
Adenoid cystic carcinoma of the breast - an aggressive presentation with pulmonary, kidney, and brain metastases: a case reportHasnae Alaoui Mhamdi, Hampig Raphael Kourie, Christiane Jungels, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2021
Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center studyAnouk Goudsmit, Edouard Cubilier, Anne-Pascale Meert, et al.
Cold Spring Harbor Molecular Case Studies|March 2, 2023
<i>PIK3CA</i> copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancerOttavia Amato, Laurence Buisseret, Géraldine Gebhart, et al.
Cancers|July 2, 2021
HER2-Low Breast Cancer: Molecular Characteristics and PrognosisElisa Agostinetto, Mattia Rediti, Danai Fimereli, et al.
Therapeutic Advances in Medical Oncology|July 12, 2023
Antibody-drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatmentGuilherme Nader-Marta, Chiara Molinelli, Véronique Debien, et al.
Anti-Cancer Drugs|September 10, 2016
Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumorsSandrine Aspeslagh, Ahmad Awada, Arturo S Matos-Pita, et al.
Future Oncology (London, England)|August 21, 2019
EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancerAditya Bardia, Philippe Aftimos, Teeru Bihani, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Seminars in Cancer Biology|December 27, 2017
Network science in clinical trials: A patient-centered approachVenkata S K Manem, Roberto Salgado, Philippe Aftimos, et al.
Breast (Edinburgh, Scotland)|May 6, 2014
Cardiotoxicity of systemic agents used in breast cancerFelipe Ades, Dimitrios Zardavas, Ana Catarina Pinto, et al.
The Oncologist|July 21, 2021
Analyses of the Rationale and Implementation of Research Biopsies in Oncology Clinical Trials at a Tertiary Cancer CenterNathalie Olympios, Laetitia Collet, Marianne Paesmans, et al.
Journal of Medical Case Reports|October 30, 2017
Adenoid cystic carcinoma of the breast - an aggressive presentation with pulmonary, kidney, and brain metastases: a case reportHasnae Alaoui Mhamdi, Hampig Raphael Kourie, Christiane Jungels, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2021
Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center studyAnouk Goudsmit, Edouard Cubilier, Anne-Pascale Meert, et al.
Cold Spring Harbor Molecular Case Studies|March 2, 2023
<i>PIK3CA</i> copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancerOttavia Amato, Laurence Buisseret, Géraldine Gebhart, et al.
Cancers|July 2, 2021
HER2-Low Breast Cancer: Molecular Characteristics and PrognosisElisa Agostinetto, Mattia Rediti, Danai Fimereli, et al.
Therapeutic Advances in Medical Oncology|July 12, 2023
Antibody-drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatmentGuilherme Nader-Marta, Chiara Molinelli, Véronique Debien, et al.
Anti-Cancer Drugs|September 10, 2016
Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumorsSandrine Aspeslagh, Ahmad Awada, Arturo S Matos-Pita, et al.
Future Oncology (London, England)|August 21, 2019
EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancerAditya Bardia, Philippe Aftimos, Teeru Bihani, et al.
Pageof 9